Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration

Go back to Barclays Maintains an 'Overweight' on Allscripts-Misys Healthcare (MDRX); Tone Into 4Q: Focus on Eclipsys Growth, Progress on Merger Integration
Allscripts-Misys Healthcare Solution (AMEX: MDRX) Delayed: 4.96 --0 (-0%)
Previous Close $4.96    52 Week High $15.78 
Open $4.96    52 Week Low $9.80 
Day High $4.96    P/E N/A 
Day Low $4.96    EPS $-0.59 
Volume 1,500